Revenue
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Trinity Biotech PLC (TRIB)
Price$9.47Cached quote
Net income
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $43.8M | $61.6M | $56.8M | $62.5M | $81.1M | $102.0M | $90.4M | $97.0M | $99.1M | $99.6M | $100.2M |
| Gross profit | $16.9M | $21.4M | $19.4M | $17.3M | $33.5M | $48.6M | $38.1M | $41.4M | $41.9M | $43.5M | $46.5M |
| Gross margin | 38.57% | 34.83% | 34.22% | 27.62% | 41.23% | 47.64% | 42.15% | 42.72% | 42.25% | 43.65% | 46.42% |
| Research & development | $3.6M | $4.5M | $4.4M | $4.1M | $4.5M | $5.1M | $5.3M | $5.4M | $5.7M | $5.0M | $5.1M |
| Operating expenses | $28.3M | $42.6M | $46.5M | $36.6M | $29.5M | $48.5M | $62.2M | $61.7M | $79.6M | $83.3M | $33.0M |
| Operating income | −$11.4M | −$21.2M | −$27.0M | −$19.3M | $3.9M | $82,000 | −$24.1M | −$20.2M | −$37.7M | −$39.8M | $13.5M |
| Operating margin | −26.07% | −34.38% | −47.59% | −30.95% | 4.85% | 0.08% | −26.66% | −20.85% | −37.99% | −40.00% | 13.48% |
| EBITDA | −$21.4M | −$21.0M | −$27.0M | −$19.3M | $41.9M | $122,000 | −$24.1M | −$20.1M | −$37.1M | −$39.4M | $13.6M |
| EBITDA margin | −48.83% | −34.05% | −47.59% | −30.95% | 51.68% | 0.12% | −26.66% | −20.76% | −37.46% | −39.59% | 13.55% |
| Net income | −$37.4M | −$31.2M | −$36.9M | −$43.6M | −$1.9M | −$6.0M | −$29.0M | −$22.7M | −$38.7M | −$38.6M | $22.2M |
| Net profit margin | −85.36% | −50.71% | −64.87% | −69.71% | −2.28% | −5.90% | −32.06% | −23.35% | −39.00% | −38.73% | 22.14% |
| Basic EPSper basic share | — | -$53.10 | -$480.00 | -$182.40 | $6.00 | — | — | — | — | — | — |
| Diluted EPSper diluted share | — | -$53.10 | -$480.00 | -$182.40 | $6.00 | — | — | — | — | — | — |
Owners
Reported shareholders
Reported holdings Number of shares
View holders
| Holder | Shares held |
|---|---|
HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC | 661.21K |
Williams & Novak, LLC | 140.54K |
Cambridge Investment Research Advisors, Inc. | 44.56K |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 26.86K |
Moss Adams Wealth Advisors LLC | 25.67K |
INSPIRION WEALTH ADVISORS, LLC | 25K |
RAYMOND JAMES FINANCIAL INC | 20.32K |
BECKER CAPITAL MANAGEMENT INC | 18K |
LPL Financial LLC | 17.67K |
GEODE CAPITAL MANAGEMENT, LLC | 12.6K |
RHUMBLINE ADVISERS | 9.37K |
JONES FINANCIAL COMPANIES LLLP | 3.64K |
OSAIC HOLDINGS, INC. | 3.5K |
WELLS FARGO & COMPANY/MN | 2.5K |
Farther Finance Advisors, LLC | 2K |
UBS Group AG | 1.11K |
MORGAN STANLEY | 400 |
SIMPLEX TRADING, LLC | 354 |
ATWOOD & PALMER INC | 20 |
CoreCap Advisors, LLC | 1 |
Bars compare reported share counts. A matching total for this share class and reporting period is unavailable, so percentages are not shown.
Source: SEC Form 13F ↗Updated Sep 29, 2026 · Quarterly data